GlassScriptPhysician profile
Ashley Hopkins
NPI 1417239096
$3,426.53
in general payments reported to CMS, 2019-2025
15 companies · $1,591 in 2025
The $1,591 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $32.02 · 2023: $611 · 2024: $1,193 · 2025: $1,591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,185 · Education: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,184.88 |
| Education | $209.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $693.62 | 2023-2025 | Tremfya |
| Abbvie INC. | $560.54 | 2022-2025 | |
| Amgen INC. | $397.15 | 2023-2025 | Otezla, Otezla |
| Ucb, INC. | $268.99 | 2023-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $260.62 | 2023-2025 | |
| Incyte Corporation | $189.79 | 2023-2025 | Opzelura, Opzelura |
| Lilly USA, LLC | $167.23 | 2024-2025 | Ebglyss, Taltz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.63 | 2023-2024 | Spevigo, Cyltezo |
| Leo Pharma INC. | $159.21 | 2024-2025 | Adbry |
| Galderma Laboratories, L.P. | $153.34 | 2024-2025 | Nemluvio |
| E.R. Squibb & Sons, L.L.C. | $145.93 | 2023-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $116.85 | 2025 | |
| Sun Pharmaceutical Industries INC. | $102.95 | 2023-2024 | Ilumya, Winlevi |
| Regeneron Healthcare Solutions, INC. | $30.57 | 2025 | Libtayo |
| Strata Skin Sciences, INC. | $17.11 | 2024 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hopkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.